{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T13:50:21Z","timestamp":1756993821988,"version":"3.37.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T00:00:00Z","timestamp":1601337600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e0 degli Studi di Roma La Sapienza"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objectives<\/jats:title>\n                <jats:p>Aim of this study was to evaluate the association between cerebral microbleeds (CMBs) and white matter disease (WMD) with intracerebral hemorrhage (ICH) after intravenous thrombolysis (IVT) with rt-PA. We also evaluated whether CMBs characteristics and WMD burden correlate with symptomatic ICH and outcome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We included acute ischemic stroke (AIS) patients treated with IVT. The number and location of CMBs as well as severity of WMD were rated analyzing pre- or post-treatment MRI. Multivariable regression analysis was used to determine the impact of CMB and WMD on ICH subgroups and outcome measures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>434 patients were included. CMBs were detected in 23.3% of them. ICH occurred in 34.7% of patients with CMBs. Independent predictors of parenchymal hemorrhage were the presence of CMBs (OR 2.724, 95% CI 1.360\u20135.464, <jats:italic>p<\/jats:italic> = 0.005) as well as cortical-subcortical stroke (OR 3.629, 95% CI 1.841\u20137.151, <jats:italic>p<\/jats:italic> &lt; 0.001) and atherothrombotic stroke subtype (OR 3.381, 95% CI 1.335\u20138.566, <jats:italic>p<\/jats:italic> = 0.010). Either the presence, or number, and location of CMBs, as well as WMD, was not independently associated with the development of SICH. No independent association between the presence, number, or location of CMBs or WMD and outcome measures was observed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>The results of our study suggest that the exclusion of eligible candidates to administration of IV rt-PA only on the basis of CMBs presence is not justified. The clinical decision should be weighed with a case-by-case approach. Additional data are needed to evaluate the benefit-risk profile of rt-PA in patients carrying numerous microbleeds.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10072-020-04720-y","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T07:03:01Z","timestamp":1601362981000},"page":"1969-1976","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hemorrhagic risk after intravenous thrombolysis for ischemic stroke in patients with cerebral microbleeds and white matter disease"],"prefix":"10.1007","volume":"42","author":[{"given":"Maria Luisa","family":"Capuana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Svetlana","family":"Lorenzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Chiara","family":"Caselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Paciaroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2735-8427","authenticated-orcid":false,"given":"Danilo","family":"Toni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,29]]},"reference":[{"key":"4720_CR1","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1161\/01.STR.0000199847.96188.12","volume":"37","author":"A Viswanathan","year":"2006","unstructured":"Viswanathan A, Chabriat H (2006) Cerebral microhemorrhage. Stroke 37:550\u2013555","journal-title":"Stroke"},{"key":"4720_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/S1474-4422(09)70013-4","volume":"8","author":"SM Greenberg","year":"2009","unstructured":"Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, al-Shahi Salman R, Warach S, Launer LJ, van Buchem M, Breteler MM, Microbleed Study Group (2009) Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 8:165\u2013174","journal-title":"Lancet Neurol"},{"key":"4720_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000356796","volume":"37","author":"L Pantoni","year":"2014","unstructured":"Pantoni L, Fierini F, Poggesi A (2014) Thrombolysis in acute stroke patients with cerebral small vessel disease. Cerebrovasc Dis 37:5\u201313","journal-title":"Cerebrovasc Dis"},{"key":"4720_CR4","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1159\/000139658","volume":"26","author":"AM Demchuk","year":"2008","unstructured":"Demchuk AM, Khan F, Hill MD, Barber PA (2008) et NINDS rt-PA Stroke Study Group. Importance of leukoaraiosis on CT for tissue plasminogen activator decision making: evaluation of the NINDS rt-PA stroke study. Cerebrovasc Dis 26:120\u2013125","journal-title":"Cerebrovasc Dis"},{"issue":"7","key":"4720_CR5","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1111\/ijs.12604","volume":"10","author":"D Toni","year":"2015","unstructured":"Toni D, Mangiafico S, Agostoni E, Bergui M, Cerrato P, Ciccone A, Vallone S, Zini A, Inzitari D (2015) Intravenous thrombolysis and intra-arterial interventions in acute ischemic stroke: Italian Stroke Organisation (ISO)-SPREAD guidelines. Int J Stroke 10(7):1119\u20131129","journal-title":"Int J Stroke"},{"key":"4720_CR6","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1161\/STROKEAHA.108.526996","volume":"40","author":"C Cordonnier","year":"2009","unstructured":"Cordonnier C, Potter GM, Jackson CA, Doubal F, Keir S, Sudlow CLM, Wardlaw JM, Salman RAS (2009) Observer MicroBleed Scale (BOMBS) Improving interrater agreement about brain microbleeds: development of the brain. Stroke 40:94\u201399","journal-title":"Stroke"},{"key":"4720_CR7","doi-asserted-by":"publisher","first-page":"351","DOI":"10.2214\/ajr.149.2.351","volume":"149","author":"F Fazekas","year":"1987","unstructured":"Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA (1987) MR signal abnormalities at 1.5 T in Alzheimer\u2019s dementia and normal aging. AJR Am J Roentgenol 149:351\u2013356","journal-title":"AJR Am J Roentgenol"},{"key":"4720_CR8","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1161\/01.STR.32.2.438","volume":"32","author":"V Larrue","year":"2001","unstructured":"Larrue V, von Kummer R, Muller A et al (2001) Risk factors for severe hemorrhagic transformation in ischemic stroke patients treated with recombinant tissue plasminogen activator: a secondary analysis of the European-Australasian Acute Stroke Study (ECASS II). Stroke 32:438\u2013441","journal-title":"Stroke"},{"key":"4720_CR9","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S0140-6736(07)60149-4","volume":"369","author":"N Wahlgren","year":"2007","unstructured":"Wahlgren N, Ahmed N, D\u00e1valos A, Ford GA, Grond M, Hacke W, Hennerici MG, Kaste M, Kuelkens S, Larrue V, Lees KR, Roine RO, Soinne L, Toni D, Vanhooren G (2007) SITS MOST investigators. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST): an observational study. Lancet 369:275\u2013282","journal-title":"Lancet"},{"key":"4720_CR10","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.1056\/NEJM199512143332401","volume":"333","author":"The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group","year":"1995","unstructured":"The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group (1995) Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333:1581\u20131587","journal-title":"N Engl J Med"},{"key":"4720_CR11","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","volume":"19","author":"J van Swieten","year":"1988","unstructured":"van Swieten J, Koudstaal P, Visser M et al (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604\u2013607","journal-title":"Stroke"},{"key":"4720_CR12","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fneur.2013.00205","volume":"4","author":"PA Yates","year":"2014","unstructured":"Yates PA, Villemagne VL, Ellis KA et al (2014) Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations. Front Neurol 4:205","journal-title":"Front Neurol"},{"key":"4720_CR13","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1161\/STROKEAHA.116.012992","volume":"48","author":"A Charidimou","year":"2017","unstructured":"Charidimou A, Turc G, Oppenheim C, Yan S, Scheitz JF, Erdur H, Klinger-Gratz PP, el-Koussy M, Takahashi W, Moriya Y, Wilson D, Kidwell CS, Saver JL, Sallem A, Moulin S, Edjlali-Goujon M, Thijs V, Fox Z, Shoamanesh A, Albers GW, Mattle HP, Benavente OR, J\u00e4ger HR, Ambler G, Aoki J, Baron JC, Kimura K, Kakuda W, Takizawa S, Jung S, Nolte CH, Lou M, Cordonnier C, Werring DJ (2017) Microbleeds, cerebral hemorrhage, and functional outcome after stroke thrombolysis: individual patient data meta-analysis. Stroke 48:2084\u20132090","journal-title":"Stroke"},{"issue":"6","key":"4720_CR14","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1001\/jamaneurol.2016.0292","volume":"73","author":"G Tsivgoulis","year":"2016","unstructured":"Tsivgoulis G, Zand R, Katsanos AH, Turc G, Nolte CH, Jung S, Cordonnier C, Fiebach JB, Scheitz JF, Klinger-Gratz PP, Oppenheim C, Goyal N, Safouris A, Mattle HP, Alexandrov AW, Schellinger PD, Alexandrov AV (2016) Risk of symptomatic intracerebral hemorrhage after intravenous thrombolysis in patients with acute ischemic stroke and high cerebral microbleed burden. A Meta-analysis JAMA Neurol 73(6):675\u2013683","journal-title":"A Meta-analysis JAMA Neurol"},{"issue":"3","key":"4720_CR15","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1016\/j.jstrokecerebrovasdis.2016.11.127","volume":"26","author":"R Zand","year":"2017","unstructured":"Zand R, Tsivgoulis G, Singh M, McCormack M, Goyal N, Ishfaq MF, Shahripour RB, Nearing K, Elijovich L, Alexandrov AW, Liebeskind DS, Alexandrov AV (2017) Cerebral microbleeds and risk of intracerebral hemorrhage post intravenous thrombolysis. J Stroke Cerebrovasc Dis 26(3):538\u2013544","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"4720_CR16","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12883-018-1029-0","volume":"18","author":"MA Chacon-Portillo","year":"2018","unstructured":"Chacon-Portillo MA, Llinas RH, Marsh EB (2018) Cerebral microbleeds shouldn\u2019t dictate treatment of acute stroke: a retrospective cohort study evaluating risk of intracerebral hemorrhage. BMC Neurol 18:33","journal-title":"BMC Neurol"},{"issue":"3","key":"4720_CR17","doi-asserted-by":"publisher","first-page":"73","DOI":"10.12779\/dnd.2018.17.3.73","volume":"17","author":"L Juyoun","year":"2018","unstructured":"Juyoun L, Eun Hee S, Eungseok O et al (2018) Characteristics of cerebral microbleeds. Dement Neurocogn Disord 17(3):73\u201382","journal-title":"Dement Neurocogn Disord"},{"key":"4720_CR18","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1161\/STROKEAHA.113.001778","volume":"44","author":"K Kimura","year":"2013","unstructured":"Kimura K, Aoki J, Shibazaki K, Saji N, Uemura J, Sakamoto Y (2013) New appearance of extraischemic microbleeds on T2*-weighted magnetic resonance imaging 24 hours after tissue-type plasminogen activator administration. Stroke 44:2776\u20132781","journal-title":"Stroke"},{"issue":"6","key":"4720_CR19","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1161\/CIRCULATIONAHA.115.016261","volume":"132","author":"S Akoudad","year":"2015","unstructured":"Akoudad S, Portegies MLP, Koudstaal PJ, Hofman A, van der Lugt A, Ikram MA, Vernooij MW (2015) Cerebral microbleeds are associated with an increased risk of stroke. The Rotterdam Study Circulation 132(6):509\u2013516","journal-title":"The Rotterdam Study Circulation"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04720-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04720-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04720-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,29]],"date-time":"2021-09-29T00:44:21Z","timestamp":1632876261000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04720-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,29]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["4720"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04720-y","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"type":"print","value":"1590-1874"},{"type":"electronic","value":"1590-3478"}],"subject":[],"published":{"date-parts":[[2020,9,29]]},"assertion":[{"value":"6 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This research study was conducted retrospectively from data obtained for clinical purposes. All of the procedures were performed in accordance with the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}